Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma Patients

Currently known serum biomarkers do not predict clinical outcome in melanoma. S100-beta is widely established as a reliable prognostic indicator in patients with advanced metastatic disease but is of limited predictive value in tumor-free patients. This study was aimed to determine whether molecular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical oncology 2005-08, Vol.23 (22), p.5088-5093
Hauptverfasser: MIAN, Shahid, UGUREL, Selma, PARKINSON, Erika, SCHLENZKA, Iris, DRYDEN, Ian, LANCASHIRE, Lee, BALL, Graham, CREASER, Colin, REES, Robert, SCHADENDORF, Dirk
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!